Ritalin is named as an intervention in 3 current clinical trials in our Israel and Sweden registers. 3 are recruiting patients now. The most common phase is Phase 2. The sponsor with the most trials is University of Haifa (2). The most-studied condition is Posttraumatic Stress Disorder.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Efficacy of Reboxetine and Methylphenidate Treatment on Attentional, Sensory and Emotional Dysregulation in Adults With PTSD
NCT05133804 · ClinicalTrials.gov ↗ · Posttraumatic Stress Disorder
|
Phase 2 | Recruiting | University of Haifa | Israel |
|
The Efficacy of a Pharmacological Treatment (Reboxetine Plus Ritalin) Versus Dog-Assisted Therapy in PTSD
NCT07771530 · ClinicalTrials.gov ↗ · PTSD, Posttraumatic Stress Disorder
|
Phase 2 | Recruiting | University of Haifa | Israel |
|
Acoustic and Vestibular Noise as Possible Non-pharmacological Treatment of ADHD in School Children
NCT03425669 · ClinicalTrials.gov ↗ · ADHD
|
Not applicable | Recruiting | Lund University | Sweden |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Lead sponsor | Trials |
|---|---|
| University of Haifa | 2 |
| Lund University | 1 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Israel | 2 | 2 |
| Clinical trials in Sweden | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
3 current trials in our Israel and Sweden registers name Ritalin as a drug or biological intervention, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 3 of the 3 trials are recruiting: 2 with sites in Israel and 1 with sites in Sweden. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
University of Haifa (2) and Lund University (1). The number in brackets is how many trials each organisation leads.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Ritalin works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Ritalin works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Ritalin (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 26 Sep 2026.